(Q44295533)

1 December 2017

title

Improved beta-cell function after standardized weight reduction in severely obese subjects (English)

1 reference

1 December 2017

0 references

0 references

2

Bo Ahrén

1 reference

1 December 2017

Marie Guldstrand

1

1 reference

1 December 2017

Ulf Adamson

series ordinal

3

1 reference

1 December 2017

publication date

1 March 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

1 December 2017

published in

1 reference

1 December 2017

volume

284

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

E557-65

1 reference

Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells).

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Leptin selectively decreases visceral adiposity and enhances insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Accurate assessment of beta-cell function: the hyperbolic correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Update: NIH consensus conference. Gastrointestinal surgery for severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

The adipoinsular axis: effects of leptin on pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Fasting blood glucose in determining the prevalence of diabetes in a large, homogeneous population of Caucasian middle-aged women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Islet dysfunction in obese women with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Fatty acids, lipotoxicity and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00325.2002

10.1152/AJPENDO.00325.2002

21 January 2018

Identifiers

DOI

1 reference

release_d5vant5yvbhrzgi56ho4ygxau4

1 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d5vant5yvbhrzgi56ho4ygxau4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference